1. Academic Validation
  2. Sphingolipid signaling in kidney diseases

Sphingolipid signaling in kidney diseases

  • Am J Physiol Renal Physiol. 2025 Feb 11. doi: 10.1152/ajprenal.00193.2024.
Ningjun Li 1 Guangbi Li 1
Affiliations

Affiliation

  • 1 Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA23298.
Abstract

Sphingolipids are a family of bioactive lipids. The key components include ceramides, ceramide-1-phosphate, sphingosine, and sphingosine-1-phosphate. Sphingolipids were originally considered to be primarily structural elements of cell membranes, but later recognized as bioactive signaling molecules that play diverse roles in cellular behaviors such as cell differentiation, migration, proliferation, and death. Studies have demonstrated changes in key components of sphingolipids in the kidneys under different conditions and their important roles in the renal function and the pathogenesis of various kidney diseases. This review summarizes the most recent advances in the role of sphingolipid signaling in kidney diseases.

Figures
Products